Smith Group Asset Management’s Phibro Animal Health PAHC Stock Holding History

Smith Group Asset Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	25,021 -2,334	-9%	-$111K	0.07%	76
2025 Q4	$1.02M	Buy	27,355 +676	+3%	+$27.5K	0.05%	91
2025 Q3	$1.08M	Buy	26,679 +805	+3%	+$26.6K	0.06%	88
2025 Q2	$661K	Hold	25,874	–	–	0.04%	115
2025 Q1	$553K	Buy	25,874 +99	+0.4%	+$2.21K	0.04%	128
2024 Q4	$541K	Buy	+25,775	New	+$596K	0.04%	139
2019 Q2	–	Sell	-3,790	Closed	-$125K	–	444
2019 Q1	$125K	Sell	3,790 -11,900	-76%	-$370K	﹤0.01%	245
2018 Q4	$505K	Sell	15,690 -400	-2%	-$15.1K	0.02%	191
2018 Q3	$690K	Buy	+16,090	New	+$760K	0.02%	188

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Smith Group Asset Management's PAHC Position: Q1 2026 in Review

Smith Group Asset Management reduced its Phibro Animal Health (PAHC) stake by 8.5% in Q1 2026, selling an estimated $111K and leaving 25,021 shares worth $1.38M. The position accounts for 0.07% of the portfolio, ranked #76.

Smith Group Asset Management first reported a position in PAHC in Q3 2018 and has held it in 9 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Smith Group Asset Management held 25,021 shares of Phibro Animal Health worth $1.38M as of Q1 2026.
Smith Group Asset Management sold 2,334 Phibro Animal Health shares in Q1 2026, an estimated $111K.
Phibro Animal Health made up 0.07% of Smith Group Asset Management's portfolio in Q1 2026, its #76 holding.
Smith Group Asset Management first reported a position in Phibro Animal Health in Q3 2018 and has held it in 9 quarters since.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Smith Group Asset Management's 13F filing for Q1 2026, filed 18 May 2026.